Encube Ethicals IPO
ENCUB
Open Date
To be announced
Close Date
To be announced
Price Range
To be announced
Min Investment
To be announced
Lot Size
To be announced
Listing at
NSE/BSE
Issue Size
To be announced
IPO Document
Free Demat with Zero AMC*
About Encube Ethicals Ltd IPO
Incorporated in September 1995, Encube Ethicals Limited is a pharmaceutical formulations company focused on topical and transdermal products. The company serves customers across 50 countries, including regulated markets such as the US, UK, Europe, and India. Its operations are divided into three key segments: Global Generics, Global CDMO, and India Branded Formulations, covering product development, manufacturing, regulatory support, and commercialisation.
Encube operates regulatory-approved manufacturing facilities backed by dedicated R&D capabilities and a growing product pipeline. The company has established relationships with global pharmaceutical players and has built a strong position in the US topical generics market. In India, it also markets branded topical products through its established distribution network.
As of March 31, 2026, Encube had 1,695 permanent employees and 982 factory workers across its manufacturing, R&D, quality, supply chain, finance, IT, and commercial functions.
Incorporated in September 1995, Encube Ethicals Limited is a pharmaceutical formulations company focused on topical and transdermal products. The company serves customers across 50 countries, including regulated markets such as the US, UK, Europe, and India. Its operations are divided into three key segments: Global Generics, Global CDMO, and India Branded Formulations, coverin
Encube Ethicals IPO Subscription Breakdown
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | -- |
| Non-Institutional Investors (NIIs) | 15% | -- |
| Retail Individual Investors (RIIs) | 35% | -- |
Encube Ethicals IPO Strengths & Weaknesses
Regulatory-approved manufacturing facilities with established quality and compliance systems.
Strong R&D capabilities supporting product development and innovation.
Integrated presence across generics, CDMO, and branded formulations.
Growing position in the US topical generics market with established global customer relationships.
Experienced management team with expertise in pharmaceutical manufacturing and business growth.
Encube Ethicals IPO Important Dates & Issue Details
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| -- | -- | -- |
| Issue Composition: | |
|---|---|
| Face Value | ₹1 per share |
| Total Issue Size | 0 shares (aggregating up to To be announced) |
| Fresh Issue | 0 shares (aggregating up to To be announced) |
| Offer for Sale | 0 shares of ₹1 (aggregating up to To be announced) |
| Issue Type | Book Building IPO |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 80.91 shares |
| Post-Issue Shareholding | 0 shares |
Encube Ethicals IPO Lot Size and Investment Details
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Encube Ethicals ipo has been designed to ensure broad participation while maintaining optimal price discovery.
How to Apply for Encube Ethicals IPO
- Log in to your Choice account
- Select IPO
- Enter the number of lots and your price
- Verify UPI ID
- Complete the transaction on your UPI app
Encube Ethicals IPO Contact & Registrar Details
Contact Details
Address
803 B Wing H D I L Kaledonia Sahar Road Mumbai
Phone Number
Registrar Details
Registrar Name
MUFG Intime India Pvt.Ltd.
Phone Number
Optivalue Tek Consulting Ltd IPO Lead Manager(s)
| Book Running Lead Manager(s) |
|---|
| JM Financial Ltd | Axis Capital Ltd | Kotak Mahindra Capital Co Ltd |